EmGenisys
PrivateLast Round
Seed
Jul 23, 2025
Total Funding Raised
$2.1M
Company Overview
EmGenisys operates in Healthcare & Life Sciences and is based in Texas. Its latest recorded funding round was a Seed round in July 2025.
EmGenisys is an ag-tech company that provides a SaaS platform using artificial intelligence to analyze embryo health and improve pregnancy outcomes for assisted reproductive techniques in livestock.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Computer Vision, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
EmGenisys Comparables
Compare EmGenisys with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Verility Inc. | 74% | |
| Vytelle | 66% | |
| IMV Technologies | 60% |
For institutional investors. Book with your work email.
EmGenisys Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Jul 23, 2025 | ||||
| Grant | Sep 26, 2024 | ||||
| Seed Round | Sep 25, 2024 | ||||
| Grant | Aug 27, 2024 | ||||
| Grant | Jan 9, 2023 | ||||
Accelerator | Sep 23, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
EmGenisys Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tall Grass Ventures | Seed |
| American Farm Bureau Federation | Grant |
| Grit Road Partners | Seed |
| Cornell University Office of University Investments | Grant |
| Ag Ventures Alliance | Seed |
| Luminate Accelerator | Accelerator |
| BioTools Innovator | Grant |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 23, 2025
$1.5M raised in Seed round.
- Sep 26, 2024
$250K grant received from BioTools Innovator.
For institutional investors. Book with your work email.
EmGenisys Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about EmGenisys's valuation, stock price, and market status.
Is EmGenisys a public or private company?
EmGenisys is a private company.
What is the current stock price of EmGenisys?
EmGenisys is a private company, so its shares have no public market price. Caplight tracks EmGenisys's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is EmGenisys worth (valuation)?
Valuation information for EmGenisys is not publicly available.
Can I buy EmGenisys stock?
EmGenisys shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was EmGenisys's last funding round?
EmGenisys's most recent funding round was Seed on July 23, 2025.
Who are the main investors in EmGenisys?
Key investors in EmGenisys include Grit Road Partners.
Will EmGenisys IPO soon?
No public IPO plans have been announced for EmGenisys.
How can I track EmGenisys secondary market activity?
Caplight tracks bids, offers, and trades in EmGenisys's shares on secondary markets.